Integrated insular phenotype (IIP) versus Berger-Sanai and Yasargil classifications: comparative prognostic value in surgery of insular gliomas

整合岛叶表型(IIP)与Berger-Sanai和Yasargil分类:岛叶胶质瘤手术预后价值的比较

阅读:1

Abstract

BACKGROUND: Surgery of insular gliomas remains one of the most demanding areas in neuro-oncology. Traditional classifications (Berger-Sanai, Yasargil) have limited prognostic value. We evaluated the Integrated Insular Phenotype (IIP), an ordinal system reflecting tumor complexity and its associations with surgical outcomes. METHODS: We retrospectively analyzed 167 patients with histologically confirmed insular gliomas. For each case, tumor topography was classified according to Berger-Sanai, Yasargil, and IIP systems. Three binary outcomes were assessed: extent of resection (EOR), seizure control, and persistent neurological deficit at day 90. Logistic regression models were applied to evaluate associations, and performance was assessed using odds ratios (OR), AUC, AIC, and LR χ(2). RESULTS: Increasing IIP complexity was associated with reduced likelihood of total/subtotal resection (OR = 3.83; p < 0.001), poorer seizure control (OR = 2.90; p < 0.001), and higher risk of persistent deficits (OR = 2.83; p = 0.004). IIP showed lower AIC and higher LR χ(2) values compared with Berger-Sanai and Yasargil, indicating superior prognostic performance. While Berger-Sanai yielded high point estimates, confidence intervals were wide, and Yasargil produced consistent but less discriminative results. CONCLUSIONS: In this retrospective cohort, the Integrated Insular Phenotype (IIP) showed superior prognostic performance compared with the Berger-Sanai and Yasargil classifications. IIP more accurately reflected topographic complexity and may assist in balancing oncological radicality with functional safety. Further prospective multicenter validation is warranted.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。